Title: Target sequencing, cell experiments, and a population study establish endothelial nitric oxide synthase (eNOS) gene as hypertension susceptibility gene
Authors: Salvi, Erika
Kuznetsova, Tatiana
Thijs, Lutgarde
Lupoli, Sara
Stolarz-Skrzypek, Katarzyna
D'Avila, Francesca
Tikhonoff, Valerie
De Astis, Silvia
Barcella, Matteo
Seidlerová, Jitka
Benaglio, Paola
Malyutina, Sofia
Frau, Francesca
Velayutham, Dinesh
Benfante, Roberta
Zagato, Laura
Title, Alexandra
Braga, Daniele
Marek, Diana
Kawecka-Jaszcz, Kalina
Casiglia, Edoardo
Filipovsky, Jan
Nikitin, Yuri
Rivolta, Carlo
Manunta, Paolo
Beckmann, Jacques S
Barlassina, Cristina
Cusi, Daniele
Staessen, Jan A # ×
Issue Date: Nov-2013
Publisher: Lippincott Williams & Wilkins
Series Title: Hypertension vol:62 issue:5 pages:844-52
Article number: 10.1161/HYPERTENSIONAHA.113.01428
Abstract: A case-control study revealed association between hypertension and rs3918226 in the endothelial nitric oxide synthase (eNOS) gene promoter (minor/major allele, T/C allele). We aimed at substantiating these preliminary findings by target sequencing, cell experiments, and a population study. We sequenced the 140-kb genomic area encompassing the eNOS gene. In HeLa and HEK293T cells transfected with the eNOS promoter carrying either the T or the C allele, we quantified transcription by luciferase assay. In 2722 randomly recruited Europeans (53.0% women; mean age 40.1 years), we studied blood pressure change and incidence of hypertension in relation to rs3918226, using multivariable-adjusted models. Sequencing confirmed rs3918226, a binding site of E-twenty six transcription factors, as the single nucleotide polymorphism most closely associated with hypertension. In T compared with C transfected cells, eNOS promoter activity was from 20% to 40% (P<0.01) lower. In the population, systolic/diastolic blood pressure increased over 7.6 years (median) by 9.7/6.8 mm Hg in 28 TT homozygotes and by 3.8/1.9 mm Hg in 2694 C allele carriers (P≤0.0004). The blood pressure rise was 5.9 mm Hg systolic (confidence interval [CI], 0.6-11.1; P=0.028) and 4.8 mm Hg diastolic (CI, 1.5-8.2; P=0.0046) greater in TT homozygotes, with no differences between the CT and CC genotypes (P≥0.90). Among 2013 participants normotensive at baseline, 692 (34.4%) developed hypertension. The hazard ratio and attributable risk associated with TT homozygosity were 2.04 (CI, 1.24-3.37; P=0.0054) and 51.0%, respectively. In conclusion, rs3918226 in the eNOS promoter tags a hypertension susceptibility locus, TT homozygosity being associated with lesser transcription and higher risk of hypertension.
ISSN: 0194-911X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Hypertension and Cardiovascular Epidemiology
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
13-27-P.pdf Published 1952KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science